peripheral blood lymphocytes of a melanoma patient ( av ) were activated in an autologous-mixed-lymphocyte tumor culture ( amltc ) and responding cells were cloned using irradiated autologous melanoma cells ( av-mel ) as antigen source , ebv-transformed b-lymphoblasts as feeder cells and recombinant interleukin 2 .
C0025202
patient
C1513095
melanoma cells